Jeffrey Pearlnman, 49, of Edgewood, N.J., was arrested Thursday on a federal criminal complaint that charges him with engaging in a kickback scheme that defrauded federal healthcare programs.
As alleged in the complaint, from approximately September 2012 until December 2015, Pearlman was employed by a pharmaceutical company that manufactured and sold a fentanyl-based sublingual spray that was approved by the Food and Drug Administration solely for the management of breakthrough pain in cancer patients. The company first hired Pearlman as a sales representative and subsequently promoted him to the position of District Sales Manager (DSM). As a DSM, PEARLMAN was responsible for managing the company’s sales representatives who called on licensed healthcare providers in Connecticut, New York, New Jersey and Rhode Island.
It is alleged that Pearlman and the sales representatives he managed induced certain physicians, advanced practice registered nurses (APRNs) and physicians’ assistants to prescribe the pharmaceutical company’s fentanyl spray by paying them to participate in hundreds of sham “Speaker Programs.” The Speaker Programs, which were typically held at high-end restaurants, were ostensibly designed to gather licensed healthcare professionals who had the capacity to prescribe the fentanyl spray and educate them about the drug. In truth, the events were usually just a gathering of friends and co-workers, most of whom did not have the ability to prescribe the fentanyl spray, and no educational component took place. “Speakers” were paid a fee that ranged from $1,000 to several thousand dollars for attending these dinners. At times, the sign-in sheets for the Speaker Programs were forged, with PEARLMAN’s knowledge, so as to make it appear that the programs had an appropriate audience of healthcare professionals.
It is alleged that the pharmaceutical company paid one Connecticut healthcare provider who participated in these sham Speaker Programs a total of approximately $83,000 in illegal kickbacks in order to induce the provider to prescribe the company’s fentanyl spray over similar medications. PEARLMAN authorized these payments.
It is alleged that Pearlman personally profited from this scheme through inflated quarterly bonuses he received that were based in large part on the sales results of the sales representatives he managed.
It is further alleged that this illegal kickback scheme caused millions of dollars of losses to federal healthcare programs.
Pearlman appeared today before U.S. Magistrate Judge Sarah A. L. Merriam in New Haven and was released on a $200,000 bond.
The charge of paying or receiving kickbacks in relation to a federal healthcare program carries a maximum term of imprisonment of five years and a fine of up to $250,000.